Ovarian cancer can be detected with cell-free DNA blood test
A new epigenomic blood test may distinguish between cancerous and benign ovarian tumours with greater accuracy than current tests...
cfDNA (circulating DNA or cell-free DNA) are fragments of DNA that are released into the blood.
Elevated levels are seen in cancer and they can be detected using 'liquid biopsies' to aid diagnosis. Fetal cfDNA can be detected in maternal blood through non-invasive prenatal testing.
by Jen Willows
A new epigenomic blood test may distinguish between cancerous and benign ovarian tumours with greater accuracy than current tests...
A blood test taken in the first trimester of pregnancy to measure cell-free DNA methylation can help to predict the risk of preterm pre-eclampsia...
Results from an NHS-based clinical trial show the potential of a blood test to detect over 50 types of cancer...
by Jake Knox
A Texas court has awarded $100 million more damages to a company whose patents for non-invasive prenatal testing technology were infringed by a competitor...
Prenatal genetic test results need to be communicated better, according to the US Food and Drug Administration...
Health regulators in five countries are investigating non-invasive prenatal test NIFTY, over data protection concerns....
Non-invasive prenatal testing to detect chromosomal abnormalities in twin pregnancies is not as accurate as in singleton pregnancies...
A long-running court case over non-invasive prenatal testing patents has been settled...
by Eleanor Mackle and 1 others
Canadian researchers have published two new studies using machine learning to improve detection and treatment of cancer...
The largest genetic analysis of China's population to date has been carried out on over 140,000 pregnant women, revealing new insights into migration patterns and disease risk in Chinese people...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.